ATEME financials
ATEME
969500I4RF06BPM4AN82 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €95.6M | €93.5M |
| Cost of sales | €37.4M | €39.3M |
| Gross profit | €58.2M | €54.2M |
| Operating profit (EBIT) | €3.9M | -€3.9M |
| Finance costs | €1.5M | €1.4M |
| Profit before tax | €924.0K | -€4.7M |
| Income tax expense | -€27.0K | €638.0K |
| Profit for the year | €952.0K | -€5.4M |
| — attributable to owners | €952.0K | -€5.4M |
| — attributable to NCI | €0 | €0 |
| Total comprehensive income | €1.1M | -€5.1M |
| Per share | ||
| Basic EPS | €0.08 | €-0.47 |
| Diluted EPS | €0.08 | €-0.47 |
| Free cash flow / share | €0.46 | €0.19 |
| Cash flow statement | ||
| Net cash from operating activities | €6.3M | €3.9M |
| Net cash from investing activities | -€2.0M | -€2.9M |
| Purchase of PP&E (capex) | €837.0K | €1.7M |
| Purchase of intangibles | €0 | €18.0K |
| Net cash from financing activities | -€8.2M | €2.9M |
| Repayments of borrowings | €7.4M | €4.4M |
| Lease liability payments | €989.0K | €873.0K |
| Balance sheet | ||
| Total assets | €112.4M | €118.5M |
| Non-current assets | €30.4M | €31.7M |
| Property, plant & equipment | €2.9M | €3.8M |
| Right-of-use assets | €4.1M | €4.0M |
| Intangible assets & goodwill | €12.9M | €12.9M |
| Current assets | €81.9M | €86.8M |
| Inventories | €4.6M | €6.9M |
| Trade & other receivables | €44.0M | €43.7M |
| Cash & equivalents | €5.3M | €9.5M |
| Total equity | €35.6M | €33.6M |
| — attributable to owners | €35.6M | €33.6M |
| Non-current liabilities | €18.5M | €26.7M |
| Long-term borrowings | €12.5M | €21.5M |
| Lease liabilities (non-current) | €3.9M | €3.3M |
| Current liabilities | €58.2M | €58.2M |
| Short-term borrowings | €13.8M | €10.9M |
| Lease liabilities (current) | €801.0K | €1.1M |
| Deferred tax liabilities | €0 | €11.0K |
| Derived metrics | ||
| Free cash flow | €5.4M | €2.2M |
| Operating margin | 4.1% | -4.2% |
| Net margin | 1.0% | -5.7% |
| Return on equity | 2.7% | -16.0% |
| Cash conversion ratio | 6.58× | -0.73× |
| Capex coverage | 7.49× | 2.24× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | €2.2M | €1.3M |
| Adjustments For Decrease Increase In Other Operating Receivables | -€1.4M | -€3.7M |
| Adjustments For Decrease Increase In Trade Account Receivable | -€1.5M | -€6.9M |
| Adjustments For Deferred Tax Expense | -€16.0K | €658.0K |
| Adjustments For Finance Income Cost | -€1.4M | -€1.4M |
| Adjustments For Increase Decrease In Other Current Liabilities | €3.8M | €11.6M |
| Adjustments For Increase Decrease In Trade Account Payable | -€4.0M | -€1.5M |
| Adjustments For Provisions | €279.0K | €136.0K |
| Adjustments For Sharebased Payments | €773.0K | €652.0K |
| Bank Overdrafts Classified As Cash Equivalents | €0 | €35.0K |
| Cancellation of Treasury Shares | -€13.0K | -€5.0K |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €5.3M | €9.4M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €7.7M | €1.6M |
| Comprehensive Income Attributable To Noncontrolling Interests | €0 | €0 |
| Comprehensive Income Attributable To Owners of Parent | €1.1M | -€5.1M |
| Current Payables On Social Security and Taxes Other Than Income Tax | €9.5M | €10.1M |
| Deferred Tax Assets | €1.3M | €1.4M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€121.0K | €41.0K |
| Equity and Liabilities | €112.4M | €118.5M |
| Finance Income | €122.0K | €11.0K |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | -€1.6M | €544.0K |
| General and Administrative Expense | €6.7M | €6.4M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €0 | €57.0K |
| Increase Decrease In Cash and Cash Equivalents | -€4.1M | €3.9M |
| Increase Decrease In Working Capital | €1.4M | -€2.3M |
| Increase Decrease Through Sharebased Payment Transactions | €773.0K | €652.0K |
| Intangible Assets Other Than Goodwill | €7.9M | €8.1M |
| Interest Paid Classified As Financing Activities | €983.0K | €709.0K |
| Interest Received Classified As Investing Activities | €72.0K | €11.0K |
| Issue of Equity | €165.0K | — |
| Issued Capital | €1.6M | €1.6M |
| Noncurrent Provisions For Employee Benefits | €2.1M | €1.9M |
| Number of Shares Outstanding | 11.6M | 11.5M |
| Other Adjustments To Reconcile Profit Loss | €5.0K | -€26.0K |
| Other Comprehensive Income | €135.0K | €288.0K |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €100.0K | €229.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €35.0K | €116.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €35.0K | €116.0K |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €100.0K | €172.0K |
| Other Longterm Provisions | €0 | €0 |
| Other Noncurrent Financial Assets | €1.4M | €1.4M |
| Payments For Development Project Expenditure | €1.2M | €1.1M |
| Proceeds From Sale Or Issue of Treasury Shares | €169.0K | €0 |
| Research and Development Expense | €23.4M | €23.1M |
| Reserve of Exchange Differences On Translation | €579.0K | €545.0K |
| Reserve of Remeasurements of Defined Benefit Plans | -€19.0K | -€119.0K |
| Retained Earnings Excluding Profit Loss For Reporting Period | €5.0M | €9.7M |
| Retained Earnings Profit Loss For Reporting Period | €952.0K | -€5.4M |
| Sales and Marketing Expense | €24.2M | €28.6M |
| Share Premium | €27.4M | €27.3M |
| Trade and Other Current Payables To Trade Suppliers | €10.2M | €14.4M |
Every line item above is a fact tagged in ATEME's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.